Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiencyKim L. Ho, Gary D. Lopaschuk, Liyan Zhang et al.|Cardiovascular Research|2019Cited by 195
The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activityRami Al Batran, John R. Ussher|JCI Insight|2019Cited by 18
The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA:3-Ketoacid CoA TransferaseSeyed Amirhossein Tabatabaei Dakhili, John R. Ussher, Amanda A. Greenwell et al.|Diabetes|2022Cited by 14
An isoproteic cocoa butter-based ketogenic diet fails to improve glucose homeostasis and promote weight loss in obese miceAmanda A. Greenwell, John R. Ussher, Jordan S. F. Chan et al.|American Journal of Physiology-Endocrinology and Metabolism|2022Cited by 13
The antianginal ranolazine fails to improve glycaemia in obese liver‐specific pyruvate dehydrogenase deficient male miceChristina T. Saed, John R. Ussher, Seyed Amirhossein Tabatabaei Dakhili et al.|Basic & Clinical Pharmacology & Toxicology|2023Cited by 1